This course has expired. Voir les cours disponibles.
Neurology
MS & NMOSD: Optimizing the Standard of Care – Virtual Learning Series
Multiple sclerosis (MS) is a chronic disease associated with significant patient burden. Early treatment remains crucial to slowing inflammation and delay or prevent disability by reducing the frequency of relapses and MRI lesions. This program reviews the disease burden and discusses different treatment options for patients with MS. The overall goal is to increase clinicians’ confidence in choosing an approach to MS treatment that will optimize patient outcomes.
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series.
Durée
5 hr
Profession
Physician
# des crédits
5.5
Accréditation
MOC - Section 1, SCFHS
Date d'expiration
2023-02-04
Multiple sclerosis (MS) is a chronic disease associated with significant patient burden. Early treatment remains crucial to slowing inflammation and delay or prevent disability by reducing the frequency of relapses and MRI lesions. This program reviews the disease burden and discusses different treatment options for patients with MS. The overall goal is to increase clinicians’ confidence in choosing an approach to MS treatment that will optimize patient outcomes.
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series.
La Faculté
Mohammed Al Jumah, MBBS,MD,FRCPC
Yaser Al Malik MD,FRCPC, ABPN, CSCN (EEG & EMG)
Hani Aggad, MD
Hajer Yousef Almudaiheem, Director of Drug Policy and Regulation at Deputyship of Therapeutic Affairs at Ministry of Health Saudi Arabia
Hany Aggad, MD
Mona Alkhawajah, MD
Hind Alnajashi, MD
Amani Alshehri, B Pharm, PharmD, BCPS, RPh, PGY2
Rola Alarieh, MSN, BSN, CNS, RN
Objectifs d'apprentissage
Upon completion of this continuing education program, participants will be better able to:
- Discuss the clinical difference between slowly escalating treatment versus starting early with high-efficacy treatment.
- Describe the different safety profiles and monitoring requirements for the various medications used to treat multiple sclerosis.
- Optimize the management of patients with multiple sclerosis before, during, and after pregnancy.